The Lawyer’s new China Elite report contains the most detailed research available on the PRC legal market and contains unparalleled insight into the country's leading law firms. They vary in size, practice focus and geographic coverage, but they all share one common quality – ambition... Read more
This year, The Lawyer’s annual ranking of the largest UK law firms by turnover is available as an interactive, digital benchmarking tool. For the first time this will allow you to manipulate each data set against the metrics of your choice.
Baker & McKenzie (B&M) partner Stewart Saxe has been forced to resign from his position on the board of Canadian pharmaceutical company Draxis Health after B&M tightened its corporate governance rules.
Since long before most lawyers had even heard of messrs Sarbanes and Oxley, the firm has had a rule in place that required its lawyers to seek consent from the firm’s professional responsibility and practice committee in order to sit on the board of a for-profit company. Now that rule has hardened and directorships are no longer tolerated.
“I think Enron was a watershed event for many different reasons. Although we were already well along the road in stopping lawyers from sitting on the boards of for-profit companies, now standards have tightened in Baker & McKenzie,” commented Saxe.
Saxe had sat on the board of Draxis Health for 17 years. As a labour and employment lawyer, he has advised the company on the implementation of its corporate governance and employee relations policies.
Lawyers from around B&M’s international network sit on the professional responsibility and practice committee, which decides all of the firm’s conflict rules.